Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts

Cancer Research

Volumn 61, Issue 7, 2001, Pages 2996-3001

  Ng, Bruce ^a   Kramer, Elissa ^b,d   Liebes, Leonard ^c,d   Wasserheit, Caroline ^c,d   Hochster, Howard ^c,d   Blank, Edward ^e   Ceriani, Roberto ^e   Furmanski, Philip ^a,d  

^a NEW YORK UNIVERSITY   (United States)

^b Division of Nuclear Medicine   (United States)

^c Department of Surgery   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Cancer Research Fund of Contra Costa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY Y 90; PENTETIC ACID; TOPOTECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOSENSITIZATION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BONE MARROW; BREAST NEOPLASMS; CELL DIVISION; COMBINED MODALITY THERAPY; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOTOXINS; MICE; MICE, NUDE; PENTETIC ACID; RADIATION TOLERANCE; RADIOIMMUNOTHERAPY; TOPOTECAN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS; YTTRIUM RADIOISOTOPES;

EID: 0035300411     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cancer statistics
2. Treatment of leukemia with radiolabeled monoclonal antibodies
3. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: Results of a Phase 1 clinical trial
4. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer
5. In vivo tumor targeting of a recombinant single-chain antigen-binding protein
6. Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates
7. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells
8. Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation
9. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin
10. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives
11. DNA topoisomemse 1-targeted chemotherapy of human colon cancer in xenografts
12. Phase I trial of low-dose continuous topotecan infusion in patients with cancer: An active and well-tolerated regimen
13. Activity and pharmacodynamics of 21-day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy
14. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis
15. Biological activity of two humanized antibodies against two different breast cancer antigens and comparison to their original murine forms
16. Quantitation of human mammary epithelial antigens in cells cultured from normal and cancerous breast tissues
17. Effect of prolonged topotecan infusion on topoisomerase 1 levels: A Phase I and pharmacodynamic study
18. 90Y-Lym-1 for Raji lymphoma xenografts
19. Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts
20. Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: A matched analysis
21. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: Preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial
22. The potential of topoisomerase 1 inhibitors in the treatment of CNS malignancies: Report of a synergistic effect between topotecan and radiation
23. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts
24. Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice
25. Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations
26. Radiation-induced apoptosis: Relevance to radiotherapy
27. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
28. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin
29. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75
30. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase